Table 3.
Unadjusted and adjusted factors associated with used needle and syringe borrowing during follow-up, among participants with recently acquired HCV infection in the ATAHC study (n=124)
| Characteristic | OR | 95% CI | P | aOR¶ | 95% CI | P |
|---|---|---|---|---|---|---|
| HCV treatment (vs. none) | 1.01 | 0.92, 1.10 | 0.877 | 0.99 | 0.89, 1.07 | 0.655 |
| Age (per 10 year increase) | 0.98 | 0.93, 1.03 | 0.473 | - | - | - |
| Gender | ||||||
| Male | 1.00 | - | - | - | - | - |
| Female | 1.08 | 0.98, 1.19 | 0.115 | 1.11 | 1.00, 1.24 | 0.064 |
| Transgender | 0.92 | 0.69, 1.24 | 0.589 | - | - | - |
| Owned/rental accommodation (vs. none) | 1.04 | 0.89, 1.22 | 0.598 | - | - | - |
| Tertiary education or greater (vs. none) | 0.97 | 0.90, 1.06 | 0.511 | - | - | - |
| Full-time or part-time employment (vs. none) | 0.94 | 0.86, 1.04 | 0.232 | - | - | - |
| Social functioning | ||||||
| 0–9 | 1.00 | - | - | - | - | - |
| ≥10–16 | 1.08 | 0.95, 1.22 | 0.228 | - | - | - |
| >16 | 1.16 | 1.03, 1.31 | 0.015 | - | - | - |
| Injecting drug use (vs. none)* | 1.05 | 0.95, 1.15 | 0.356 | - | - | - |
| Use of a sterile needle and syringe for all injections (vs. none) * | 0.84 | 0.76, 0.94 | 0.002 | - | - | - |
| Used needle and syringe borrowing (vs. none)* | 1.49 | 1.31, 1.70 | <0.001 | 1.52 | 1.33, 1.75 | <0.001 |
| Lending someone else a used needle or syringe (vs. none)* | 1.21 | 1.07, 1.37 | 0.002 | - | - | - |
| Ancillary injecting equipment sharing (vs. none)* | 1.12 | 1.02, 1.24 | 0.023 | - | - | - |
| Current opiate substitution therapy (vs. none) | 0.63 | 0.36, 1,03 | 0.068 | 0.77 | 0.53, 1.16 | 0.399 |
¶
adjusted odds ratio,
*
injecting drug use and injecting drug use behaviours at enrolment, defined over the one month prior to enrolment